As of 2025-06-26, the Fair Value of Leap Therapeutics Inc (LPTX) is -8.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.28 USD, the upside of Leap Therapeutics Inc is -3,079.58%.
With the market price of 0.28 USD and our fair value calculation, Leap Therapeutics Inc (LPTX) is not a good investment. Investing in LPTX stocks now will result in a potential loss of 3,079.58%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -27.51 | -40.59 | -54.60 | -81.41 | -67.56 | -54.33 |
| YoY growth | 16.37% | -47.51% | -34.52% | -49.12% | 17.02% | -19.55% |
| Market Cap (mil) | 14.16 |
| P/E | |
| Forward P/E |
| EPS | -1.67 |
| Avg earnings growth rate | -19.55% |
| TTM earnings | -69.17 |